NO942502L - Blanding for å gjöre det lettere å slutte å röyke - Google Patents

Blanding for å gjöre det lettere å slutte å röyke

Info

Publication number
NO942502L
NO942502L NO942502A NO942502A NO942502L NO 942502 L NO942502 L NO 942502L NO 942502 A NO942502 A NO 942502A NO 942502 A NO942502 A NO 942502A NO 942502 L NO942502 L NO 942502L
Authority
NO
Norway
Prior art keywords
pct
composition
easier
mixture
make
Prior art date
Application number
NO942502A
Other languages
English (en)
Other versions
NO942502D0 (no
NO308123B1 (no
Inventor
Richard L Jones
Original Assignee
Univ Alberta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Alberta filed Critical Univ Alberta
Publication of NO942502D0 publication Critical patent/NO942502D0/no
Publication of NO942502L publication Critical patent/NO942502L/no
Publication of NO308123B1 publication Critical patent/NO308123B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Otolaryngology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Confectionery (AREA)
  • Cosmetics (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO942502A 1992-01-03 1994-07-01 Sprayanordning og aerosolblanding for utposjonering av en oppløsning av nikotin eller et farmasøytisk akseptabelt salt derav NO308123B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929200047A GB9200047D0 (en) 1992-01-03 1992-01-03 Nicotine-containing nasal spray
PCT/CA1993/000003 WO1993012764A1 (en) 1992-01-03 1993-01-04 Composition to help stop smoking

Publications (3)

Publication Number Publication Date
NO942502D0 NO942502D0 (no) 1994-07-01
NO942502L true NO942502L (no) 1994-09-02
NO308123B1 NO308123B1 (no) 2000-07-31

Family

ID=10708064

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942502A NO308123B1 (no) 1992-01-03 1994-07-01 Sprayanordning og aerosolblanding for utposjonering av en oppløsning av nikotin eller et farmasøytisk akseptabelt salt derav

Country Status (21)

Country Link
US (1) US5656255A (no)
EP (1) EP0619729B1 (no)
JP (1) JP3830158B2 (no)
KR (2) KR950700055A (no)
AT (1) ATE182070T1 (no)
AU (1) AU664415B2 (no)
CA (1) CA2127253C (no)
CZ (1) CZ294555B6 (no)
DE (1) DE69325643T2 (no)
DK (1) DK0619729T3 (no)
ES (1) ES2135460T3 (no)
FI (1) FI111049B (no)
GB (1) GB9200047D0 (no)
GR (1) GR3031075T3 (no)
HU (1) HUT73247A (no)
NO (1) NO308123B1 (no)
NZ (1) NZ246533A (no)
RU (1) RU2118897C1 (no)
SK (1) SK282336B6 (no)
UA (1) UA37201C2 (no)
WO (1) WO1993012764A1 (no)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9310412D0 (en) * 1993-05-20 1993-07-07 Danbiosyst Uk Nasal nicotine system
AUPM835394A0 (en) * 1994-09-23 1994-10-13 King, Michael G. Dr. Method for controlling or eliminating the need to smoke tobacco, and for treating ailments which may lead to the said need
JPH11507810A (ja) * 1995-06-05 1999-07-13 ヒューマン ジノーム サイエンシーズ，インコーポレイテッド Ｇタンパク質副甲状腺ホルモンレセプターｈｌｔｄｇ７４
CA2231968A1 (en) * 1998-03-11 1999-09-11 Smoke-Stop, A Partnership Consisting Of Art Slutsky Method of producing a nicotine medicament
GB9806937D0 (en) 1998-03-31 1998-05-27 Procter & Gamble A spray device
CA2359813C (en) * 2000-10-24 2008-04-22 Richard L. Jones Nicotine mucosal spray
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
US7645442B2 (en) 2001-05-24 2010-01-12 Alexza Pharmaceuticals, Inc. Rapid-heating drug delivery article and method of use
US20030051728A1 (en) 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound
SE0102197D0 (sv) * 2001-06-20 2001-06-20 Pharmacia Ab New product and use and manufacture thereof
SE521512C2 (sv) 2001-06-25 2003-11-11 Niconovum Ab Anordning för administrering av en substans till främre delen av en individs munhåla
DE60105820D1 (de) * 2001-10-22 2004-10-28 Pera Ivo E Zusammensetzung zur Reduzierung oder Entwöhnung von Nikotinabhängigkeit
SE0104388D0 (sv) * 2001-12-27 2001-12-27 Pharmacia Ab New formulation and use and manufacture thereof
US20030159702A1 (en) * 2002-01-21 2003-08-28 Lindell Katarina E.A. Formulation and use manufacture thereof
US20030171408A1 (en) * 2002-03-11 2003-09-11 Caplan Jay L. Therapeutic method of delivering a medicament to avoid irritating effects on membranes of user
SE0201669D0 (sv) * 2002-06-03 2002-06-03 Pharmacia Ab New formulation and use thereof
US7767698B2 (en) * 2002-06-03 2010-08-03 Mcneil Ab Formulation and use thereof
US20040002520A1 (en) * 2002-07-01 2004-01-01 Soderlund Patrick L. Composition and method for cessation of Nicotine cravings
US20040105818A1 (en) 2002-11-26 2004-06-03 Alexza Molecular Delivery Corporation Diuretic aerosols and methods of making and using them
US7913688B2 (en) 2002-11-27 2011-03-29 Alexza Pharmaceuticals, Inc. Inhalation device for producing a drug aerosol
SI1578422T1 (sl) 2002-12-20 2007-12-31 Niconovum Ab Fizikalno in kemiäśno stabilni nikotin in mikrokristal na celulozo vsebujoäś material iz trdnih delcev
CA2526475A1 (en) 2003-05-21 2004-12-02 Alexza Pharmaceuticals, Inc. Optically ignited or electrically ignited self-contained heating unit and drug-supply unit employing same
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
CA2580329C (en) 2004-09-13 2015-01-06 Chrono Therapeutics Inc. Biosynchronous transdermal drug delivery
US7766018B2 (en) 2004-09-30 2010-08-03 Smoke-Break, Inc. Device and composition for reducing the incidence of tobacco smoking
US8322350B2 (en) 2004-12-30 2012-12-04 Philip Morris Usa Inc. Aerosol generator
US8323683B2 (en) 2005-05-18 2012-12-04 Mcneil-Ppc, Inc. Flavoring of drug-containing chewing gums
AU2007224584A1 (en) 2006-03-16 2007-09-20 Niconovum Ab Improved snuff composition
US20080216828A1 (en) 2007-03-09 2008-09-11 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device
EP2322167A1 (en) * 2007-04-02 2011-05-18 Parkinson's Institute Methods and Compositions for Reduction of Side Effects of Therapeutic Treatments
MY175165A (en) * 2007-11-30 2020-06-12 Japan Tobacco Inc Aerosol-generating liquid for use in aerosol inhalator
EP2233134A1 (en) 2009-03-27 2010-09-29 McNeil AB Multi-portion intra-oral dosage form with organoleptic properties
WO2011087393A1 (ru) * 2010-01-18 2011-07-21 Общество С Ограниченной Ответственностью "Вегавольт" Композиция растительного происхождения, предназначенная для вдыхания дыма, образующегося при ее сжигании
US20110268809A1 (en) 2010-04-28 2011-11-03 Paul Andrew Brinkley Nicotine-Containing Pharmaceutical Compositions
US20110274628A1 (en) 2010-05-07 2011-11-10 Borschke August J Nicotine-containing pharmaceutical compositions
WO2013006643A1 (en) 2011-07-06 2013-01-10 The Parkinson's Institute Compositions and methods for treatment of symptoms in parkinson's disease patients
US20130078307A1 (en) 2011-09-22 2013-03-28 Niconovum Usa, Inc. Nicotine-containing pharmaceutical composition
US9907748B2 (en) 2011-10-21 2018-03-06 Niconovum Usa, Inc. Excipients for nicotine-containing therapeutic compositions
AU2016211330A1 (en) 2015-01-28 2017-08-03 Chrono Therapeutics Inc. Drug delivery methods and systems
WO2016145373A1 (en) 2015-03-12 2016-09-15 Chrono Therapeutics Inc. Craving input and support system
US10532046B2 (en) 2015-12-03 2020-01-14 Niconovum Usa, Inc. Multi-phase delivery compositions and products incorporating such compositions
US20170165252A1 (en) 2015-12-10 2017-06-15 Niconovum Usa Inc. Protein-enriched therapeutic composition
JP2019512470A (ja) * 2016-02-29 2019-05-16 ニコゲン リミテッド ニコチン配合物及びエアロゾル
EP3565617A1 (en) 2017-01-06 2019-11-13 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
SE541358C2 (en) 2017-05-30 2019-08-13 Enorama Pharma Ab Nicotine-containing chewing gum compositions
US11596779B2 (en) 2018-05-29 2023-03-07 Morningside Venture Investments Limited Drug delivery methods and systems
CN112384504A (zh) 2018-06-15 2021-02-19 R.J.雷诺兹烟草公司 烟碱的纯化
CZ309558B6 (cs) * 2021-05-25 2023-04-12 Consumer Brands International s.r.o. Náplň nikotinového prostředku, zejména nikotinového sáčku a způsob jeho výroby

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2030862A (en) * 1978-04-10 1980-04-16 Smith A A composition for treating drug addiction such as smoking nicotine-containing products
DE3241437A1 (de) * 1982-11-10 1984-05-10 Ferdinand Prof. Dr.med. 6901 Wilhelmsfeld Schmidt Mittel zum zwecke der raucherentwoehnung und/oder fuer nebenwirkungsfreien nikotingenuss bei suchtrauchern
GB2133691B (en) * 1983-01-21 1986-05-21 Leo Ab Smoking substitutes for nasal administration
GB8301659D0 (en) * 1983-01-21 1983-02-23 Leo Ab Smoking substitutes
US4920989A (en) * 1985-04-25 1990-05-01 Regents Of The University Of California Method and apparatus for aiding in the reduction of incidence of tobacco smoking
US4953572A (en) * 1985-04-25 1990-09-04 Rose Jed E Method and apparatus for aiding in the reduction of incidence of tobacco smoking
US4715387A (en) * 1985-08-23 1987-12-29 The Regents Of The Univ. Of California Aerosol for use in the reduction of tobacco smoking
SE8601351D0 (sv) * 1986-03-24 1986-03-24 Nilsson Sven Erik Styrd administration av fysiologiskt aktiva emnen
GB8614805D0 (en) * 1986-06-18 1986-07-23 British American Tobacco Co Aerosol device

Also Published As

Publication number Publication date
FI943173A (fi) 1994-09-01
ATE182070T1 (de) 1999-07-15
FI111049B (fi) 2003-05-30
GR3031075T3 (en) 1999-12-31
GB9200047D0 (en) 1992-02-26
KR950700055A (ko) 1995-01-16
NO942502D0 (no) 1994-07-01
KR100317426B1 (no) 2001-11-30
UA37201C2 (uk) 2001-05-15
DE69325643D1 (de) 1999-08-19
EP0619729A1 (en) 1994-10-19
SK282336B6 (sk) 2002-01-07
NZ246533A (en) 1996-04-26
US5656255A (en) 1997-08-12
NO308123B1 (no) 2000-07-31
WO1993012764A1 (en) 1993-07-08
HU9402003D0 (en) 1994-09-28
CA2127253A1 (en) 1993-07-08
DK0619729T3 (da) 2000-04-17
HUT73247A (en) 1996-07-29
EP0619729B1 (en) 1999-07-14
RU2118897C1 (ru) 1998-09-20
AU664415B2 (en) 1995-11-16
DE69325643T2 (de) 2000-02-10
RU94040387A (ru) 1996-10-20
JP3830158B2 (ja) 2006-10-04
FI943173A0 (fi) 1994-07-01
CA2127253C (en) 1999-09-21
ES2135460T3 (es) 1999-11-01
SK79694A3 (en) 1995-06-07
JPH07504164A (ja) 1995-05-11
CZ294555B6 (cs) 2005-02-16
CZ160894A3 (en) 1995-09-13
AU3340393A (en) 1993-07-28

Similar Documents

Publication Publication Date Title
NO942502L (no) Blanding for å gjöre det lettere å slutte å röyke
US5810018A (en) Method, composition and apparatus for reducing the incidence of cigarette smoking
CA2359813A1 (en) Nicotine mucosal spray
JPH07114679B2 (ja) 喫煙停止補助手段として使用するか、あるいは禁煙区域で使用する手段
JPH072654A (ja) 吸入によるタウリン投与装置
JPH034195B2 (no)
JPS61254170A (ja) ニコチン調製物
WO1996000071A1 (en) Treatment of nicotine craving and/or smoking withdrawal symptoms with a liquid nasal composition containing nicotine and caffeine or xanthine
Prignot Pharmacological approach to smoking cessation
WO1996000069A1 (en) Treatment of nicotine craving and/or smoking withdrawal symptoms with a solid or semi-solid composition containing nicotine and caffeine or xanthine, especially for nasal administration
Gay et al. “An ‘Ho, Ho, Baby, Take a Whiff on Me”: La Dama Blanca Cocaine in Current Perspective
Yoshihara et al. Long lasting smooth muscle relaxation by a novel PACAP analogue in guinea‐pig and primate airways in vitro
Hill et al. Consumer applications of chemical principles: Drugs
JP3037828U (ja) 喫煙習慣矯正具
WO2023096535A1 (ru) Средство для бросающих курить
PL172210B1 (pl) Srodek antynikotynowy PL
SU1537259A1 (ru) Средство, подавл ющее влечение к никотину и табачному дыму
Salam Cocaine-induced myocardial infarction
Milhorn et al. CNS Stimulants: Cocaine
Engel Cocaine: A Historical and Modern Perspective